Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Schulz

Showing results (61-70 of 309) with videos related to

Pageof 31
Sort By:
Expert Review of Cardiovascular Therapy|August 4, 2005
Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarctionMichael Haude, Rainer Schulz, Gerd Heusch, et al.
Basic Research in Cardiology|November 5, 2004
Regional differences of myocardial infarct development and ischemic preconditioningRainer Schulz, Petra Gres, Ina Konietzka, et al.
Current Pharmaceutical Design|February 8, 2021
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for CardioprotectionAndreas Daiber, Sebastian Steven, Gerhild Euler, et al.
Basic Research in Cardiology|December 20, 2003
TNFalpha in ischemia/reperfusion injury and heart failureRainer Schulz, Stephanie Aker, Sergej Belosjorow, et al.
Basic Research in Cardiology|March 29, 2006
No loss of cardioprotection by postconditioning in connexin 43-deficient miceGerd Heusch, Astrid Büchert, Sandra Feldhaus, et al.
IUBMB Life|April 9, 2015
Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyteSusanne Rohrbach, Christian Troidl, Christian Hamm, et al.
Empirical Economics|January 19, 2021
Real estate listings and their usefulness for hedonic regressionsJens Kolbe, Rainer Schulz, Martin Wersing, et al.
International Journal of Molecular Sciences|January 27, 2021
Importance of Cx43 for Right Ventricular FunctionKerstin Boengler, Susanne Rohrbach, Norbert Weissmann, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 15, 2002
Reduced coronary and inotropic reserves with coronary microembolizationAndreas Skyschally, Rainer Schulz, Raimund Erbel, et al.
Current Pharmaceutical Design|April 18, 2013
The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formationKerstin Boengler, Elvira Ungefug, Gerd Heusch, et al.
Pageof 31

Showing results (61-70 of 309) with videos related to

Sort By:
Pageof 31
Expert Review of Cardiovascular Therapy|August 4, 2005
Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarctionMichael Haude, Rainer Schulz, Gerd Heusch, et al.
Basic Research in Cardiology|November 5, 2004
Regional differences of myocardial infarct development and ischemic preconditioningRainer Schulz, Petra Gres, Ina Konietzka, et al.
Current Pharmaceutical Design|February 8, 2021
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for CardioprotectionAndreas Daiber, Sebastian Steven, Gerhild Euler, et al.
Basic Research in Cardiology|December 20, 2003
TNFalpha in ischemia/reperfusion injury and heart failureRainer Schulz, Stephanie Aker, Sergej Belosjorow, et al.
Basic Research in Cardiology|March 29, 2006
No loss of cardioprotection by postconditioning in connexin 43-deficient miceGerd Heusch, Astrid Büchert, Sandra Feldhaus, et al.
IUBMB Life|April 9, 2015
Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyteSusanne Rohrbach, Christian Troidl, Christian Hamm, et al.
Empirical Economics|January 19, 2021
Real estate listings and their usefulness for hedonic regressionsJens Kolbe, Rainer Schulz, Martin Wersing, et al.
International Journal of Molecular Sciences|January 27, 2021
Importance of Cx43 for Right Ventricular FunctionKerstin Boengler, Susanne Rohrbach, Norbert Weissmann, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 15, 2002
Reduced coronary and inotropic reserves with coronary microembolizationAndreas Skyschally, Rainer Schulz, Raimund Erbel, et al.
Current Pharmaceutical Design|April 18, 2013
The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formationKerstin Boengler, Elvira Ungefug, Gerd Heusch, et al.
Pageof 31